Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2750422 | 0.82 | ALDH1A1 (0.48) | ALDH1A1 | |
| SCHEMBL5968591 | 0.81 | EGLN1 (0.39) | ALDH1A1 | |
| SCHEMBL731664 | 0.81 | ALDH1A1 (0.46) | ALDH1A1 | |
| SCHEMBL733088 | 0.79 | ALDH1A1 (0.62) | ALDH1A1 | |
| SCHEMBL1768486 | 0.79 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL781568 | 0.79 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL10972290 | 0.79 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL6738571 | 0.78 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL515928 | 0.77 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL5069484 | 0.76 | LMNA (0.42) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110021765-A1 | FLUORINATED LANTHANIDE PROBES FOR 19F MAGNETIC RESONANCE APPLICATIONS | UNIVERSITY OF DURHAM (GB) | 2011-01-27 | — | — | US | disclosed |
| EP-2148881-A1 | FLUORINATED LANTHANIDE PROBES FOR 19F MAGNETIC RESONANCE APPLICATIONS | UNIVERSITY OF DURHAM (GB) | 2010-02-03 | — | — | EP | disclosed |
| WO-2008132433-A1 | FLUORINATED LANTHANIDE PROBES FOR 19F MAGNETIC RESONANCE APPLICATIONS | UNIVERSITY OF DURHAM (GB) | 2008-11-06 | — | — | WO | disclosed |
| US-20050070480-A1 | Peptide arginals and methods for treating disseminated intravascular coagulation | IVAX DRUG RESEARCH INSTITUTE LTD. (HU) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110021765-A1 | FLUORINATED LANTHANIDE PROBES FOR 19F MAGNETIC RESONANCE APPLICATIONS | SLC6A3, SLC39A3, L3MBTL3 | ALDH1A1 3488/4885 |
| US-20050070480-A1 | Peptide arginals and methods for treating disseminated intravascular coagulation | ARGLU1, PLAT, SERPINC1 | ALDH1A1 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.